Prions in the urine of patients with variant Creutzfeldt-Jakob disease

New England Journal of Medicine

Volumn 371, Issue 6, 2014, Pages 530-539

  Moda, Fabio ^a,b   Gambetti, Pierluigi ^c   Notari, Silvio ^c   Concha Marambio, Luis ^a,d   Catania, Marcella ^b   Park, Kyung Won ^a   Maderna, Emanuela ^b   Suardi, Silvia ^b   Haïk, Stéphane ^e,f   Brandel, Jean Philippe ^e,f   Ironside, James ^g   Knight, Richard ^g   Tagliavini, Fabrizio ^b   Soto, Claudio ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSIDAD DE LOS ANDES   (Chile)

^e SORBONNE UNIVERSITÉ   (France)

^f CNRS   (France)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; GENE AMPLIFICATION; HUMAN; INCUBATION TIME; MAJOR CLINICAL STUDY; NEURALGIA; NONHUMAN; PREDICTIVE VALUE; PRION DISEASE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; URINALYSIS; VARIANT CREUTZFELDT JAKOB DISEASE; WESTERN BLOTTING; ADOLESCENT; ADULT; BRAIN LEVEL; CREUTZFELDT JAKOB DISEASE; ELECTROPHORESIS; METHODOLOGY; PROTEIN ENGINEERING; PROTEIN FOLDING; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN CHEMISTRY; CREUTZFELDT-JAKOB SYNDROME; ELECTROPHORESIS; HUMANS; PROTEIN ENGINEERING; PROTEIN FOLDING; PRPSC PROTEINS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84905836913     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1404401     Document Type: Article

References (34)

1. Aguzzi A, Calella AM. Prions: protein aggregation and infectious diseases. Physiol Rev 2009;89:1105-52.
2. Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998;95:13363-83. (Pubitemid 28525623)
3. Soto C. Prion hypothesis: the end of the controversy? Trends Biochem Sci 2011;36:151-8.
4. Idem. Diagnosing prion diseases: needs, challenges and hopes. Nat Rev Microbiol 2004;2:809-19.
5. Wadsworth JD, Joiner S, Hill AF, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001;358:171-80. (Pubitemid 32718539)
6. Collinge J. Variant Creutzfeldt-Jakob disease. Lancet 1999;354:317-23. (Pubitemid 29348751)
7. Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997;389:498-501. (Pubitemid 27435325)
8. Scott MR, Will R, Ironside J, et al. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci U S A 1999;96:15137-42. (Pubitemid 30019778)
9. Gill ON, Spencer Y, Richard-Loendt A, et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ 2013;347:f5675.
10. Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000;55:1075-81.
11. Hill AF, Collinge J. Subclinical prion infection in humans and animals. Br Med Bull 2003;66:161-70. (Pubitemid 37173500)
12. Bishop MT, Hart P, Aitchison L, et al. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 2006;5:393-8.
13. Lasmézas CI, Fournier JG, Nouvel V, et al. Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: implications for human health. Proc Natl Acad Sci U S A 2001;98:4142-7. (Pubitemid 32249912)
14. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-21. (Pubitemid 38210057)
15. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-9. (Pubitemid 39070413)
16. Wroe SJ, Pal S, Siddique D, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006;368:2061-7. (Pubitemid 44855106)
17. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001;411:810-3. (Pubitemid 32588105)
18. Saá P, Castilla J, Soto C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem 2006;281:35245-52. (Pubitemid 46036562)
19. Castilla J, Saá P, Soto C. Detection of prions in blood. Nat Med 2005;11:982-5. (Pubitemid 41294444)
20. Gonzalez-Romero D, Barria MA, Leon P, Morales R, Soto C. Detection of infectious prions in urine. FEBS Lett 2008;582:3161-6.
21. Saá P, Castilla J, Soto C. Presymptomatic detection of prions in blood. Science 2006;313:92-4. (Pubitemid 44051260)
22. Morales R, Duran-Aniotz C, Diaz-Espinoza R, Camacho MV, Soto C. Protein misfolding cyclic amplification of infectious prions. Nat Protoc 2012;7:1397-409.
23. Haley NJ, Mathiason CK, Carver S, Zabel M, Telling GC, Hoover EA. Detection of chronic wasting disease prions in salivary, urinary, and intestinal tissues of deer: potential mechanisms of prion shedding and transmission. J Virol 2011;85:6309-18.
24. Murayama Y, Yoshioka M, Okada H, Takata M, Yokoyama T, Mohri S. Urinary excretion and blood level of prions in scrapie-infected hamsters. J Gen Virol 2007;88:2890-8. (Pubitemid 47555045)
25. Seeger H, Heikenwalder M, Zeller N, et al. Coincident scrapie infection and nephritis lead to urinary prion excretion. Science 2005;310:324-6. (Pubitemid 41457200)
26. Gregori L, Kovacs GG, Alexeeva I, Budka H, Rohwer RG. Excretion of transmissible spongiform encephalopathy infectivity in urine. Emerg Infect Dis 2008;14:1406-12.
27. Chen B, Morales R, Barria MA, Soto C. Estimating prion concentration in fluids and tissues by quantitative PMCA. Nat Methods 2010;7:519-20.
28. Silveira JR, Raymond GJ, Hughson AG, et al. The most infectious prion protein particles. Nature 2005;437:257-61. (Pubitemid 41294488)
29. Tixador P, Herzog L, Reine F, et al. The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog 2010;6(4):e1000859.
30. Newman PK, Todd NV, Scoones D, et al. Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate. J Neurol Neurosurg Psychiatry 2014 February 19 (Epub ahead of print).
31. Brandner S, Whitfield J, Boone K, et al. Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease. Philos Trans R Soc Lond B Biol Sci 2008;363:3755-63.
32. Head MW, Ritchie D, Smith N, et al. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol 2004;164:143-53. (Pubitemid 38364599)
33. Peden AH, Ritchie DL, Head MW, Ironside JW. Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol 2006;168:927-35. (Pubitemid 43327745)
34. Notari S, Moleres FJ, Hunter SB, et al. Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States. PLoS One 2010;5(1):e8765.